2025-521169-28-00
进行中（未招募）
1 期
A study to assess the safety and immunogenicity of a therapeutic hepatitis B virus vaccine, in healthy adults (RUBY).
AstriVax1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2025年4月28日最近更新:
概览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- AstriVax
- 入组人数
- 16
- 试验地点
- 1
概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Mathieu Peeters
Scientific
AstriVax
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers.2024-516008-41-00Virometix AG60
暂停
3 期
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer2023-506882-70-00H e x a l AG89
尚未招募
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
招募中
1 期
First in human clinical trial to evaluate the safety, tolerability and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer2022-503084-15-00Deutsches Krebsforschungszentrum (DKFZ)77
已完成
1/2 期
A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light-chain amyloidosis (RRLCA)2022-502057-33-00Sanofi-Aventis Recherche & Developpement59